Inebilizumab Interactions
There are 150 drugs known to interact with inebilizumab, along with 4 disease interactions. Of the total drug interactions, 44 are major, and 106 are moderate.
- View all 150 medications that may interact with inebilizumab
- View inebilizumab disease interactions (4)
Most frequently checked interactions
View interaction reports for inebilizumab and the medicines listed below.
- Adderall (amphetamine / dextroamphetamine)
- Advil (ibuprofen)
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Banzel (rufinamide)
- Brilinta (ticagrelor)
- Briviact (brivaracetam)
- Celexa (citalopram)
- Concerta (methylphenidate)
- Copaxone (glatiramer)
- Coumadin (warfarin)
- Cytoxan (cyclophosphamide)
- Daytrana (methylphenidate)
- Eliquis (apixaban)
- Focalin (dexmethylphenidate)
- Humira (adalimumab)
- Intuniv (guanfacine)
- Jakafi (ruxolitinib)
- Kapvay (clonidine)
- Keytruda (pembrolizumab)
- Klonopin (clonazepam)
- Lexapro (escitalopram)
- Librium (chlordiazepoxide)
- Luvox CR (fluvoxamine)
- Lyrica (pregabalin)
- Maxalt (rizatriptan)
- Nayzilam (midazolam)
- Nuedexta (dextromethorphan / quinidine)
- Oxtellar XR (oxcarbazepine)
Inebilizumab disease interactions
There are 4 disease interactions with inebilizumab which include:
More about inebilizumab
- inebilizumab consumer information
- Compare alternatives
- Side effects
- Dosage information
- During pregnancy
- Drug class: selective immunosuppressants
- En español
Related treatment guides
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.